Kaitlin Schrote
Overview
Explore the profile of Kaitlin Schrote including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez M, Burns H, Schrote K, Cichowski S, Adams K
Menopause
. 2024 Oct;
31(12):1062-1068.
PMID: 39352123
Objective: To determine unmet need for menopause care in Oregon and evaluate if insurance type is associated with receipt of care. Methods: We conducted a cross-sectional survey of patients using...
2.
Mnuk R, Schrote K, Garg B, Doshi U, Rodriguez M
Contraception
. 2024 May;
137:110491.
PMID: 38763275
Objectives: To evaluate the availability of mifepristone and misoprostol at pharmacies in a state with protective abortion legislation and variation in access by rurality. Study Design: Using a secret shopper...
3.
Edelman A, Boniface E, Schrote K, Messerle-Forbes M, ODonnell A, Jensen J, et al.
Am J Obstet Gynecol
. 2023 Apr;
229(2):145.e1-145.e9.
PMID: 37116825
Background: Some users of the etonogestrel contraceptive implant experience bothersome bleeding, which can reduce contraceptive satisfaction and continuation. Few strategies exist to manage this bleeding. The exact mechanism of progestin-induced...
4.
Rodriguez M, Skye M, Schrote K, Linz R, Pedhiwala N, Liberty A, et al.
Contraception
. 2023 Apr;
123:110054.
PMID: 37088123
Objectives: To understand how changes to in-person health care during the COVID pandemic impacted contraceptive use in Oregon's state-funded network. Study Design: A retrospective cohort of 245,600 visits (virtual and...
5.
Fuerst M, Schrote K, Garg B, Rodriguez M
BMC Womens Health
. 2022 Jul;
22(1):287.
PMID: 35820853
Objective: This study sought to determine if there was a difference in the months of oral contraception prescribed by resident physicians living in U.S. states with a 12-month supply policy...
6.
Rodriguez M, Skye M, Ramanadhan S, Schrote K, Darney B
Contraception
. 2021 Dec;
112:61-67.
PMID: 34971615
Objective: To determine whether the type (intrauterine device or implant) or timing (immediately postpartum vs interval) of postpartum long-acting reversible contraception was associated with a reduction in short interpregnancy interval...
7.
Schrote K, Hersh A, Bruegl A, Rodriguez M
J Am Pharm Assoc (2003)
. 2021 Dec;
62(3):711-716.e3.
PMID: 34930682
Background: Expanding reproductive health services in community pharmacies is a promising strategy for reaching underserved communities. Limited information exists on women's attitudes to receive these services and if interest may...
8.
Rodriguez M, Garg B, Williams S, Souphanavong J, Schrote K, Darney B
Contraception
. 2019 Dec;
101(3):210-212.
PMID: 31862410
Objective: To determine the availability of pharmacist prescribing of hormonal contraception in rural areas of two states. Study Design: Cross-sectional survey. Results: Overall, 42% of pharmacies prescribed contraception (Oregon: 46%...